| NDC Code | 84141-025-01 |
|---|
| Package Description | 1 SYRINGE, GLASS in 1 CARTON (84141-025-01) / 1 mL in 1 SYRINGE, GLASS |
|---|
| Product NDC | 84141-025 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Redemplo |
|---|
| Non-Proprietary Name | Plozasiran |
|---|
| Dosage Form | INJECTION, SOLUTION |
|---|
| Usage | SUBCUTANEOUS |
|---|
| Start Marketing Date | 20251119 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA219947 |
|---|
| Manufacturer | Arrowhead Pharmaceuticals, Inc. |
|---|
| Substance Name | PLOZASIRAN |
|---|
| Strength | 25 |
|---|
| Strength Unit | mg/.5mL |
|---|
| Pharmacy Classes | APOC-III-directed RNA Interaction [EPC], Increased RNA Degradation [PE], RNA, Small Interfering [CS], Small Interfering RNA [EPC] |
|---|